Evidence map›Paper›PMID 40659656›Full record

ArticleScientific reports2025

Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition.

Luciele Guerra Minuzzi, Helena Batatinha, Christopher Weyh, Vidya Srokshna Balasubramanian Lakshmi, Carmen Fiuza-Luces, Beatriz G Gálvez, Alejandro Lucia, Ana Maria Teixeira, Natascha Sommer, José Cesar Rosa-Neto and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. The Immune System as a Biosensor of Health and Athletic Performance.Scandinavian journal of medicine & science in sports · 2026
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luciele Guerra MinuzziExercise and Immunometabolism Research Group, Postgraduation Program in Movement Sciences, Department of Physical Education, São Paulo State University (UNESP), 305 Roberto Simonsen, Presidente Prudente, 19060-900, Brazil. luciele.minuzzi@unesp.br.
Helena BatatinhaSchool of Nutritional Sciences and Wellness, The University of Arizona, Tucson, AZ, USA.
Christopher WeyhDepartment of Exercise Physiology and Sports Therapy, Institute of Sport Science, Justus-Liebig University Giessen, Giessen, Germany.
Vidya Srokshna Balasubramanian LakshmiExcellence cluster Cardio-Pulmonary Institute (CPI), Justus-Liebig-University Giessen, Giessen, Germany.
Carmen Fiuza-LucesPhysical Exercise and Pediatric Cancer Research Group, Research Institute of the Hospital 12 de Octubre ('imas12'), Madrid, Spain.
Beatriz G GálvezPhysical Exercise and Pediatric Cancer Research Group, Research Institute of the Hospital 12 de Octubre ('imas12'), Madrid, Spain.
Alejandro LuciaPhysical Exercise and Pediatric Cancer Research Group, Research Institute of the Hospital 12 de Octubre ('imas12'), Madrid, Spain.
Ana Maria TeixeiraCIPER, Faculty of Sport Sciences and Physical Education, University of Coimbra, Coimbra, Portugal.
Natascha SommerExcellence cluster Cardio-Pulmonary Institute (CPI), Justus-Liebig-University Giessen, Giessen, Germany.
José Cesar Rosa-NetoImmunometabolism Research Group, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.
Fabio Santos LiraExercise and Immunometabolism Research Group, Postgraduation Program in Movement Sciences, Department of Physical Education, São Paulo State University (UNESP), 305 Roberto Simonsen, Presidente Prudente, 19060-900, Brazil.
Karsten KrügerDepartment of Exercise Physiology and Sports Therapy, Institute of Sport Science, Justus-Liebig University Giessen, Giessen, Germany. Karsten.krueger@sport.uni-giessen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is associated with immune dysfunction, but long-term endurance training may confer protective effects on immune cell function. This study investigates how natural killer (NK) cell phenotypes, functional markers, and metabolism differ between endurance-trained and untrained older adults. Ex vivo expanded NK cells from endurance-trained (63.6 ± 2.1 years) and untrained (64.3 ± 3.3 years) males were exposed to adrenergic blockade (propranolol; 0-200 ng/mL) or mTOR inhibition (rapamycin; 10-100 ng/mL), both with or without PMA-induced inflammatory stimulation. Flow cytometry assessed NK subsets, activation (CD38, CD57, CD107a, NKG2D), senescence (KLRG1), and inhibitory markers (PD-1, LAG-3, TIM-3, NKG2A). Seahorse analysis measured metabolic parameters. Trained participants displayed healthier immune profiles (lower NLR, SII) and higher effector NK cells with lower cytotoxic subsets. Propranolol at 100 ng/mL blunted PMA-driven increases in CD57, CD107a, and NKG2D, while potentiating regulatory markers KLRG1, LAG-3, and PD-1 in the trained group, indicating stronger immunoregulation. With rapamycin, trained NK cells preserved NKG2D and CD107a at 10 ng/mL, maintaining cytotoxicity and degranulation. In contrast, at 100 ng/mL rapamycin plus PMA, trained NK cells shifted toward an effector phenotype with higher CD57 and CD107a, yet a blunted PMA-increased LAG-3 and TIM-3, suggesting resistance to exhaustion. PD-1 and KLRG1 remained elevated, reflecting balanced immune control. Mitochondrial analysis revealed that trained NK cells exhibited higher basal and maximal OCR, greater spare respiratory capacity, and OCR/ECAR ratio, reflecting superior metabolic fitness. These findings indicate that endurance-trained older adults have NK cells with greater functional adaptability, reduced senescence, and enhanced metabolism under inflammatory and pharmacological stress.

Indexed as

Endurance TrainingKiller Cells, NaturalTOR Serine-Threonine KinasesAgedBiomarkersHumansMaleMiddle AgedPropranololSirolimusBiomarkersMTOR protein, humanPropranololSirolimusTOR Serine-Threonine KinasesMetabolic reprogrammingMitochondrial functionNatural killerPhysical exercisePropranololRapamycin

Identifiers

PMID40659656
PMCPMC12259902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.